Kim Say-June, Choi Byung-Jo, Lee Sang Chul
Department of Surgery, Daejeon St. Mary's Hospital, The Catholic University of Korea, Daeheung-dong 520-2, Jung-gu, Daejeon, Republic of Korea.
Surg Endosc. 2014 Oct;28(10):2920-30. doi: 10.1007/s00464-014-3554-2. Epub 2014 May 23.
To assess the possibility of using single-port low anterior resection (LAR) in place of conventional laparoscopic LAR.
Though single-port LS is gradually evolving, the application of single-port LS techniques in LAR have been viewed with skepticism due to technical difficulties.
Data from patients who had undergone either conventional laparoscopic LAR (n = 49) or single-port LAR (n = 67) for colorectal cancers between March 2006 and March 2013 were analyzed retrospectively.
In single-port LAR group, oncologic outcomes were satisfactory with respect to attainment of lymph nodes (23.4 ± 15.3) and surgical margins (proximal cut margin: 7.1 ± 4.6 cm, distal cut margin: 7.7 ± 5.7 cm). Single-port LAR showed acceptable clinical outcomes manifested by comparable outcomes of post-operative analgesics requirement and length of hospital stay, and by low incidence of post-operative complications (conventional laparoscopic LAR group: 30.6% vs. single-port LAR group: 14.9%; P < 0.01). Operative time was comparable between groups (conventional laparoscopic LAR group: 309 ± 93 min vs. single-port LAR group: 277 ± 106 min; P = 0.097). Throughout a series of 67 consecutive single-port LARs, no conversion to multiport or open surgery was occurred.
This study shows that single-port LAR is both safe and feasible for use in resection of colorectal cancer when performed by surgeons who are trained in conventional laparoscopic technique. If further and more extensive studies support our results, then single-port LAR can be an acceptable alternative to conventional laparoscopic LAR for treatment of colorectal cancer.
评估采用单孔腹腔镜低位前切除术(LAR)替代传统腹腔镜LAR的可能性。
尽管单孔腹腔镜手术(LS)在不断发展,但由于技术困难,单孔LS技术在LAR中的应用一直受到质疑。
回顾性分析2006年3月至2013年3月期间因结直肠癌接受传统腹腔镜LAR(n = 49)或单孔LAR(n = 67)治疗的患者数据。
在单孔LAR组中,淋巴结获取数量(23.4 ± 15.3)和手术切缘(近端切缘:7.1 ± 4.6 cm,远端切缘:7.7 ± 5.7 cm)方面的肿瘤学结果令人满意。单孔LAR显示出可接受的临床结果,表现为术后镇痛需求和住院时间相当,且术后并发症发生率较低(传统腹腔镜LAR组:30.6% vs. 单孔LAR组:14.9%;P < 0.01)。两组手术时间相当(传统腹腔镜LAR组:309 ± 93分钟 vs. 单孔LAR组:277 ± 106分钟;P = 0.097)。在连续67例单孔LAR手术中,无一例转为多孔或开放手术。
本研究表明,对于接受过传统腹腔镜技术培训的外科医生而言,单孔LAR用于结直肠癌切除既安全又可行。如果进一步的更广泛研究支持我们的结果,那么单孔LAR可成为传统腹腔镜LAR治疗结直肠癌的可接受替代方法。